Page 583 - ACCCN's Critical Care Nursing

560 P R I N C I P L E S A N D P R A C T I C E O F C R I T I C A L C A R E

36. Ho BC, Bellomo R, McGain F et al. The incidence and outcome of septic 63. Leach RM, Treacher D. The relationship between oxygen delivery and con-
shock patients in the absence of early-goal directed therapy. Critical Care sumption. Disease-Month 1994; 40: 301–68.
2006; 10(3): R80. 64. Shoemaker WC, Appel P, Kram HB, Waxman K, Lee TS et al. Prospective trial
37. Weil M. Personal commentary on the diagnosis and treatment of circulatory of supranormal values of survivors as therapeutic goals in high-risk surgical
shock states. Curr Opin Crit Care 2004; 10(4): 246–9. patients. Chest 1988; 94: 1176–86.
38. Vincent J-L. Give your patient a fast hug (at least) once a day. Crit Care Med 65. Harvey SE, Welch CA, Harrison DA, Rowan KM, Singer M. Post hoc insights
2005; 33(6): 1225–9. from PAC-Man – the UK pulmonary artery catheter trial. Crit Care Med 2008;
39. Stennett A, Gainer J. TSC for hemorrhagic shock: effects on cytokines and 36(6): 1714–21.
blood pressure. Shock 2004; 22(6): 569–74. 66. Park M, Sangean M, Volpe MdeS, Feltrim MI, Nozqwa F et al. Randomized,
40. Santry HP, Alam HB. Fluid resuscitation: past, present, and the future. Shock prospective trial of oxygen, continuous positive airway pressure, and bilevel
2010; 33(3): 229–41. positive airway pressure by face mask in acute cardiogenic pulmonary
41. Gutierrez G, Reines HD, Wulf-Gutierrez ME. Clinical review: hemorrhagic edema. Crit Care Med 2004; 32(12): 2546–8.
shock. Critical Care 2004; 8(5): 373–81. 67. Lesage A, Ramakers M, Daubin C, Verrier V, Beynier D et al. Complicated
42. Beekley A. Damage control resuscitation: a sensible approach to the acute myocardial infarction requiring mechanical ventilation in the intensive
exsanguinating surgical patient. Crit Care Med 2008; 36(7S): S267– care unit: prognostic factors of clinical outcome in a series of 157 patients.
74. Crit Care Med 2004; 32(1): 100–105.
43. Bauer M. Multiple organ failure: update on pathophysiology and treatment 68. Opie LH, Kaplan NM. Diuretics. In: Opie LH, Gersch BJ, eds. Drugs for the
strategies. Euroanesthesia: European Society of Anaesthesiology,conference heart, 6th edn. Philadelphia: Elsevier; 2005.
proceedings, Vienna, Austria; 2005. p. 203–6. 69. Jugbutt B. Nitrates in myocardial infarction. Cardiovasc Drugs Ther 1994;
44. Finfer S, Bellomo R, Boyce N, French J, Myburgh J, Norton R. A comparison 8: 635–46.
of albumin and saline for fluid resuscitation in the intensive care unit. New 70. Poole-Wilson PA, Opie LH. Digitalis, acute inotropes and inotropic dilators:
Engl J Med 2004; 350(22): 2247–56. acute and chronic heart failure. In: Opie LH,Gersch BJ, eds. Drugs for the
45. Alderson P, Bunn F, Lefebvre C, Li W, Li L, et al. Human albumin solution heart, 6th edn. Philadelphia: Elsevier; 2005.
for resuscitation and volume expansion in critically ill patients. Cochrane 71. Follath F, Cleland JGF, Just H, Papp JG, Scholz H et al. Efficacy and safety of
Database of Systematic Reviews 2004; CD001208. intravenous levosimendan compared with dobutamine in severe low-output
46. Lighthall GK, Pearl RG. Volume resuscitation in the critically ill: choosing heart failure (the LIDO study): a randomised double-blind trial. Lancet 2002;
the best solution: how do crystalloid solutions compare with colloids? J Crit 360(9328): 196–202.
Illness 2003; 18: 252–60. 72. Mebazaa A, Barraud D, Welschbillig S. Randomized clinical trials with levosi-
47. Lopez-Plaza I. Massive blood transfusion. Transfusion medicine update. Insti- mendan. Am J Cardiol 2005; 96(6A): G74–9.
tute for transfusion medicine, Available from: http://www.itxm.org/tmu/ 73. Moiseyev VS, Poder P, Andrejevs N, Ruda MV, Golikov AP et al (RUSSLAN
tmu1998/tmu4-98.htm. Study Investigators). Safety and efficacy of a novel calcium sensitizer,
48. Criddle L, Eldridge D, Walker J. Variables predicting trauma patient survival levosimendan, in patients with left ventricular failure due to an acute
following massive transfusion. J Emerg Nurs 2005; 31: 236–42. myocardial infarction: a randomized, placebo-controlled, double-blind
49. Lim N, Dubois M, De Backer D, Vincent J-L. Do all nonsurvivors of cardio- study (RUSSLAN). Eur Heart J 2002; 23(18): 1422–32.
genic shock die with a low cardiac index? Chest 2003; 124(5): 74. Rosano G, Fini M, Caminiti G, Barbaro G. Cardiac metabolism in myocardial
1885–91. ischemia. Current Pharmaceutical Design 2008; 14: 2551–62.
50. Stacy K. Shock. In: Urden L, Stacy K, Lough ME, eds. Thelan’s critical care 75. O’Connor CM, Gattis WA, Uretsky BF, Adams KF Jr, McNutty SE et al. Con-
nursing: diagnosis and management. St Louis: Mosby; 2002. tinuous intravenous dobutamine is associated with an increased risk of
51. Hofer CK, Furrer L, Matter-Ensner S, Maloigne M, Klaghofer R et al. death in patients with advanced heart failure: insights from the Flolan Inter-
Volumetric preload measurement by thermodilution: a comparison national Randomized Survival Trial (FIRST). Am Heart J 1999; 138(1Pt1):
with transoesophageal echocardiography. Br J Anaes 2005; 94(6): 78–86.
748–55. 76. Gersh BJ. Which therapy for which condition? In: Opie LH, Gersch BJ, eds.
52. Agricola E, Bove T, Oppizzi M, Marino G, Zangrillo A et al. Ultrasound Drugs for the heart, 6th edn. Philadelphia: Elsevier; 2005.
comet-tail images: a marker of pulmonary edema: a comparative study with 77. Annane D, Bellissant E, Pussard E, Asmar R, Lacombe F et al. Placebo-
wedge pressure and extravascular lung water. Chest 2005; 127(5): controlled, randomized, double-blind study of intravenous enalaprilat
1690–95. efficacy and safety in acute cardiogenic pulmonary edema. Circulation 1996;
53. Worthley L. Shock: a review of pathophysiology and management, Part 1. 94(6): 1316–24.
Crit Care Resusc 2000; 2: 55–65. 78. AIRE Study Investigators. Effect of ramipril on mortality and morbidity of
54. Lenneman A, Ooi HH. Cardiogenic shock. 2005. [Cited 2005]. Medscape. survivors of acute myocardial infarction with clinical evidence of heart
Available from: http://www.emedicine.com/MED/topic285.htm. failure: the Acute Infarction Ramipril Efficacy (AIRE) Study. Lancet 1993;
55. Di Marco JP, Gersh B, Opie LH. Antiarrhythmic drugs and strategies. In: 342(8875): 821–8.
Opie LH, Gersch B, eds. Drugs for the heart, 6th edn. Philadelphia: Elsevier 79. Murray S. Bi-level positive airway pressure (BiPAP) and acute cardiogenic
Saunders; 2005. pulmonary oedema (ACPO) in the emergency department. Aust Crit Care
56. Santoro GM, Buonamici P. Reperfusion therapy in cardiogenic shock com- 2002; 15(2): 51–63.
plicating acute myocardial infarction. Am Heart J 1999; 138(2Pt2): 80. Agarwal R, Agarwal A, Gupta D, Jindal SK et al. Non-invasive ventilation in
S126–38. acute cardiogenic pulmonary oedema. Postgrad Med J 2005; 81(960):
57. Blanton C, Thompson P. Cardiogenic shock and myocardial infarction in 19 637–43.
Australian teaching hospitals. Cardiac Society of Australia and New Zealand 81. Tallman T, Peacock W, Emerman C et al. Noninvasive ventilation
conference proceedings, 49th ASM; 2001. outcomes in 2,430 acute decompensated heart failure patients: an ADHERE
58. Carnendran L, Abboud R, Sleeper LA, Gurunathan R, Webb JG et al. Trends Registry Analysis. Academ Emerg Med 2008; 15(4): 355–62.
in cardiogenic shock: report from the SHOCK Study. The SHould we emer- 82. Bone R, Balk R, Cerra F, Dellinger R, Fein A et al. Definitions for
gently revascularize Occluded Coronaries for cardiogenic shocK? Eur Heart sepsis and organ failure and guidelines for the use of innovative
J 2001; 22(6): 472–8. therapies in sepsis. ACCP/SCCM Consensus Conference Committee Ameri-
59. Menon V, White H, LeJemtel T, Webb JG, Sleeper LA, Hochman JS. The clini- can College of Chest Physicians/Society of Critical Care Medicine. Chest
cal profile of patients with suspected cardiogenic shock due to predominant 1992; 101: 1644–55.
left ventricular failure: a report from the SHOCK Trial Registry. SHould we 83. Angus D, Wax R. Epidemiology of sepsis: an update. Crit Care Med 2001;
emergently revascularize Occluded Coronaries in cardiogenic shocK? J Am 29(7Suppl): S109–16.
Coll Cardiol 2000; 36(3SupplA): 1071–6. 84. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D et al. 2001 SCCM/
60. Hollenberg SM, Kavinsky CJ, Parrillo JE. Cardiogenic shock. Ann Intern Med ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Intens
1999; 131(1): 47–59. Care Med 2003; 29(4): 530–38.
61. Rahimtoola S. Acute rheumatic fever. In: Fuster V, Alexander R, O’Rourke RA, 85. Angus D, Burgner D, Wunderink R et al. The PIRO concept: P is for predis-
eds. Hurst’s the heart. New York: McGraw-Hill; 2004. position. Crit Care 2003; 7(3): 248–51.
62. Leach RM, Treacher DF. The pulmonary physician in critical care. Number 86. Finfer S, Bellomo R, Lipman J, French C, Dobb G, Myburgh J. Adult-
2: oxygen delivery and consumption in the critically ill. Thorax 2002; 57(2): population incidence of severe sepsis in Australian and New Zealand inten-
170–77. sive care units. Intens Care Med 2004; 30(4): 589–96.